Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study

Overview of attention for article published in BMC Pulmonary Medicine, May 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

Background Pirfenidone is an anti-fibrotic agent shown to slow the progression of idiopathic pulmonary fibrosis (IPF). However…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.